Evidence map›Paper›PMID 19594901›Full record

ArticleBMC microbiology2009

Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori.

Hung-Chuan Chiu, Tzu-Lung Lin, Jyh-Chin Yang, Jin-Town Wang

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2024
    Review
  4. Fosfomycin Resistance Evolutionary Pathways ofInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Flavodoxins as Novel Therapeutic Targets againstInternational journal of molecular sciences · 2020
    Review
  7. A Newly Discovered Drug Resistance GeneInfection and drug resistance · 2019
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Hung-Chuan ChiuDepartment of Microbiology, National Taiwan University College of Medicine, Taipei City 10051, Taiwan, Republic of China. gaki98@yahoo.com.tw
Tzu-Lung Lin
Jyh-Chin Yang
Jin-Town Wang
National Taiwan University · TWNational Taiwan University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundContamination of endoscopy equipment by Helicobacter pylori (H. pylori) frequently occurs after endoscopic examination of H. pylori-infected patients. In the hospital, manual pre-cleaning and soaking in glutaraldehyde is an important process to disinfect endoscopes. However, this might not be sufficient to remove H. pylori completely, and some glutaraldehyde-resistant bacteria might survive and be passed to the next patient undergoing endoscopic examination through unidentified mechanisms. We identified an Imp/OstA protein associated with glutaraldehyde resistance in a clinical strain, NTUH-C1, from our previous study. To better understand and manage the problem of glutaraldehyde resistance, we further investigated its mechanism.

resultsThe minimal inhibitory concentrations (MICs) of glutaraldehyde andexpression of imp/ostA RNA in 11 clinical isolates from the National Taiwan University Hospital were determined. After glutaraldehyde treatment, RNA expression in the strains with the MICs of 4-10 microg/ml was higher than that in strains with the MICs of 1-3 microg/ml. We examined the full-genome expression of strain NTUH-S1 after glutaraldehyde treatment using a microarray and found that 40 genes were upregulated and 31 genes were downregulated. Among the upregulated genes, imp/ostA and msbA, two putative lipopolysaccharide biogenesis genes, were selected for further characterization. The sensitivity to glutaraldehyde or hydrophobic drugs increased in both of imp/ostA and msbA single mutants. The imp/ostA and msbA double mutant was also hypersensitive to these chemicals. The lipopolysaccharide contents decreased in individual imp/ostA and msbA mutants and dramatically reduced in the imp/ostA and msbA double mutant. Outer membrane permeability assay demonstrated that the imp/ostA and msbA double mutation resulted in the increase of outer membrane permeability. Ethidium bromide accumulation assay demonstrated that MsbA was involved in efflux of hydrophobic drugs.

conclusionThe expression levels of imp/ostA and msbA were correlated with glutaraldehyde resistance in clinical isolates after glutaraldehyde treatment. Imp/OstA and MsbA play a synergistic role in hydrophobic drugs resistance and lipopolysaccharide biogenesis in H. pylori.

Indexed as

Anti-Bacterial AgentsATP-Binding Cassette TransportersBacterial Outer Membrane ProteinsBacterial ProteinsBlotting, SouthernCell Membrane PermeabilityDisinfectantsDrug Resistance, Multiple, BacterialEthidiumGenes, BacterialGenome, BacterialGlutaralHelicobacter pyloriHydrophobic and Hydrophilic InteractionsLipopolysaccharidesMicrobial Sensitivity TestsAnti-Bacterial AgentsATP-Binding Cassette TransportersBacterial Outer Membrane ProteinsBacterial ProteinsDisinfectantsEthidiumGlutaralLipopolysaccharidesMsbA protein, BacteriaRNA, Bacterial

Identifiers

PMID19594901
PMCPMC2719649
OpenAlexW1980910332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.